344 related articles for article (PubMed ID: 30376985)
21. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
22. [Research progress of CRISPR-Cas9 system for gene therapy].
Zhan C; Xia X
Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
[TBL] [Abstract][Full Text] [Related]
23. Recent Advances in Therapeutic Genome Editing in China.
Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
[TBL] [Abstract][Full Text] [Related]
24. Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy.
Harris E
JAMA; 2024 Jan; 331(4):280. PubMed ID: 38170544
[No Abstract] [Full Text] [Related]
25. CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia.
Zeng S; Lei S; Qu C; Wang Y; Teng S; Huang P
Hum Genet; 2023 Dec; 142(12):1677-1703. PubMed ID: 37878144
[TBL] [Abstract][Full Text] [Related]
26. The promise and challenge of therapeutic genome editing.
Doudna JA
Nature; 2020 Feb; 578(7794):229-236. PubMed ID: 32051598
[TBL] [Abstract][Full Text] [Related]
27. A new era of gene editing for the treatment of human diseases.
Kc M; Steer CJ
Swiss Med Wkly; 2019 Jan; 149():w20021. PubMed ID: 30685869
[TBL] [Abstract][Full Text] [Related]
28. Harnessing the potential of gene editing technology using CRISPR in inflammatory bowel disease.
Limanskiy V; Vyas A; Chaturvedi LS; Vyas D
World J Gastroenterol; 2019 May; 25(18):2177-2187. PubMed ID: 31143069
[TBL] [Abstract][Full Text] [Related]
29. Treatment by CRISPR-Cas9 Gene Editing - A Proof of Principle.
Malech HL
N Engl J Med; 2021 Jan; 384(3):286-287. PubMed ID: 33471982
[No Abstract] [Full Text] [Related]
30. The Cas9 Hammer-and Sickle: A Challenge for Genome Editors.
Urnov FD
CRISPR J; 2021 Feb; 4(1):6-13. PubMed ID: 33616446
[TBL] [Abstract][Full Text] [Related]
31. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
32. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
33. Induction of Fetal Hemoglobin by Gene Therapy.
Walters MC
N Engl J Med; 2021 Jan; 384(3):284-285. PubMed ID: 33471981
[No Abstract] [Full Text] [Related]
34. The Future of Genome Editing.
Cell; 2018 May; 173(6):1311-1313. PubMed ID: 29856947
[TBL] [Abstract][Full Text] [Related]
35. CRISPR editing in biological and biomedical investigation.
Huang J; Wang Y; Zhao J
J Cell Physiol; 2018 May; 233(5):3875-3891. PubMed ID: 28786481
[TBL] [Abstract][Full Text] [Related]
36. Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.
Lin J; Zhou Y; Liu J; Chen J; Chen W; Zhao S; Wu Z; Wu N
J Cell Biochem; 2017 Oct; 118(10):3061-3071. PubMed ID: 28590031
[TBL] [Abstract][Full Text] [Related]
37. Discontinued CRISPR gene therapy for sickle-cell disease improves symptoms.
Carvalho T
Nat Med; 2023 Nov; 29(11):2669-2670. PubMed ID: 37783810
[No Abstract] [Full Text] [Related]
38. CRISPR/Cas9 system and its applications in human hematopoietic cells.
Hu X
Blood Cells Mol Dis; 2016 Nov; 62():6-12. PubMed ID: 27736664
[TBL] [Abstract][Full Text] [Related]
39. Cellular function reinstitution of offspring red blood cells cloned from the sickle cell disease patient blood post CRISPR genome editing.
Wen J; Tao W; Hao S; Zu Y
J Hematol Oncol; 2017 Jun; 10(1):119. PubMed ID: 28610635
[TBL] [Abstract][Full Text] [Related]
40. Perspectives of Sickle Cell Disease Stakeholders on Heritable Genome Editing.
Hollister BM; Gatter MC; Abdallah KE; Armsby AJ; Buscetta AJ; Byeon YJJ; Cooper KE; Desine S; Persaud A; Ormond KE; Bonham VL
CRISPR J; 2019 Dec; 2(6):441-449. PubMed ID: 31742431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]